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Proteins represent an expanding class of therapeu-
tics, but their actions are limited primarily to extracel-
lular targets because most peptidic molecules fail to
enter cells. Here we identified two small proteins,
miniature protein 5.3 and zinc finger module ZF5.3,
that enter cells to reach the cytosol through rapid
internalization and escape from Rab5+ endosomes.
The trafficking pathway mapped for these molecules
differs from that of Tat and Arg8, which require trans-
port beyond Rab5+ endosomes to gain cytosolic
access. Our results suggest that the ability of 5.3
and ZF5.3 to escape from early endosomes is
a unique feature and imply the existence of distinct
signals, encodable within short sequences, that
favor early versus late endosomal release. Identifying
these signals and understanding their mechanistic
basis will illustrate how cells control the movement
of endocytic cargo and may allow researchers to
engineer molecules to follow a desired delivery
pathway for rapid cytosolic access.
INTRODUCTION
Protein represent a rapidly expanding class of therapeutic mole-
cules (Strohl and Knight, 2009), but their actions are limited
primarily to extracellular targets (Fischer, 2007; Johnson et al.,
2011) because the size and composition of most polypeptides
and peptide mimetics preclude their uptake into mammalian
cells (Luedtke et al., 2003). It has been known for over 40 years
that addition of cationic charges to a peptide or protein can aid
transport into cells (Ryser andHancock, 1965), andmany reports
have documented the utility of appending basic sequences
derived from the HIV transactivator of transcription (Tat) (Zhou
et al., 2009), D. melanogaster Antennapedia (The´odore et al.,
1995), or simply polyarginine (for example, Arg8) (Futaki et al.,
2001) to peptides or small molecules (Wender et al., 2008) to
increase their cytoplasmic access. Certain highly positivelyChemistry & Biology 19,charged proteins (Cronican et al., 2011) and toxins (Johannes
and Popoff, 2008) and certain peptide mimetics (Verdine and
Hilinski, 2012; White et al., 2011) also possess cell-penetrating
properties, but it remains unknown how one can leverage these
examples to control the precise entry pathway or enhance the
uptake of designed peptides or mimetics.
Two contrasting mechanisms have been proposed for the
cytosolic entry of cationic proteins and related molecules. The
first (ion-pair-guided passive diffusion) posits that guanidinium
side chains on the polypeptide form hydrogen bonds with cell-
surface phospholipids creating neutral ion pairs that passively
diffuse across the plasma membrane (Rothbard et al., 2005).
The secondmodel (endosomal release) asserts that endocytosis
is a major portal through which cationic polypeptides and
peptide mimetics enter the cell (Fischer, 2007). Previous in-
vestigations have attempted to distinguish between these two
models by blocking endocytosis via thermal (Derossi et al.,
1996), pharmacologic (Wadia et al., 2004; Fischer et al., 2004),
or genetic means (Ter-Avetisyan et al., 2009). The interpretation
of these experiments is complicated, however, by differences in
protein/polypeptide concentration and analytical method. For
example, incubation of living cells with cationic proteins/poly-
peptides at concentrations R10 mM leads to the formation of
nucleation zones (Duchardt et al., 2007) that transiently disrupt
membranes (Palm-Apergi et al., 2009), causing the spontaneous
release of peptide into the cytosol. Incubation of cells at lower
concentrations (%5 mM) of peptide, in the presence of drugs
that inhibit endocytosis, prevents cytoplasmic access (Wadia
et al., 2004), implying that at low concentrations, the molecules
studied cannot diffuse through the plasma membrane. More-
over, the many studies using microscopy to examine cells fixed
by treatment with formaldehyde or methanol must be reeval-
uated in light of evidence that the fixation process can release
fluorescently labeled peptides from endosomes (Belitsky et al.,
2002 and Richard et al., 2003), an artifact not observed during
microscopic examination of living cells. Finally, the high-intensity
light used during microscopy can itself facilitate the redistribu-
tion of fluorescently labeled peptides from endosomes to cyto-
plasm (Maiolo et al., 2004). Thus, whether, when, and how these
cationic molecules escape endocytic vesicles to access the
cytosol remain unanswered questions.819–830, July 27, 2012 ª2012 Elsevier Ltd All rights reserved 819
Figure 1. Miniature Protein Design
(A) Sequences of minimally cationic miniature proteins evaluated in this work.
(B) A plot of the relationship between the total number of a-helical arginine
residues (# Rtotal ) and the number of a-helical faces on which these arginines
are displayed (# Rfaces) for each aPP variant. The location of each a-helical
arginine residue is represented by a blue circle on the helical wheel.
(C) A plot of mean cellular fluorescence at 530 nm of HeLa cells treated with
fluorescently tagged miniature protein variants (5 mM, 30 min).
See also Figure S1.
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ability are complicated by the above experimental details, aswell
as by the fact that neither Tat nor Arg8 possesses a defined fold.
Miniature proteins are a family of small (36 aa), well-folded poly-
peptides that adopt a characteristic hairpin fold consisting of
axially packed a- and PPII helices (Blundell et al., 1981; Hodges
and Schepartz, 2007). Miniature proteins identified through both
rational design (Zondlo and Schepartz, 1999; Zellefrow et al.,
2006) and molecular evolution (Chin and Schepartz, 2001; Rut-
ledge et al., 2003; Golemi-Kotra et al., 2004; Gemperli et al.,
2005) canmodulate protein function by inhibiting protein interac-
tions (Rutledge et al., 2003; Gemperli et al., 2005); both loss-of-
function and gain-of-function activities have been observed
(Golemi-Kotra et al., 2004; Gemperli et al., 2005; Zellefrow
et al., 2006). We reported previously that minimally cationic mini-
ature proteins containing between 2 and 6 arginine residues
embedded within the a- or PPII helix were taken up by mamma-
lian cells in culture more efficiently than Tat or Arg8 (Daniels and
Schepartz, 2007; Smith et al., 2008). In this report we investigate
whether, when, and how miniature proteins containing arginine
access the cytoplasm.
To learn more about the structural determinants of cyto-
plasmic access, we designed a set of miniature proteins that
differed in the number and density of a-helical arginine side
chains and tracked their passage into the cell. Using low con-
centrations (1 mM) of fluorophore-conjugated variants, we found
that a minimum of four a-helical arginines was required for cell
uptake, and that uptake was enhanced when the arginines
were clustered on the same a-helix face. Next, a novel and rapid
assay for evaluating cytoplasmic access revealed that of four
cationic miniature proteins taken up by cells, only one reaches
the cytosol. This miniature protein, which we named 5.3,
possesses a distinct array of five dispersed a-helical arginines.
Live-cell confocal microscopy revealed that rhodamine-labeled
5.3 (5.3R) is taken up by an endocytic pathway that includes
Rab5+ and Rab7+ endosomes. This pathway is shared by Tat,
Arg8, and cationic miniature proteins that do not reach the
cytosol. However, for 5.3, Tat, or Arg8 to gain cytosolic access,
active endocytosis and endosomal acidification were required.
We find further that unlike Tat or Arg8, which require vesicle
maturation beyond the Rab5+ stage, miniature protein 5.3
accesses the cytosol by crossing specific membrane regions
present in early Rab5+ endosomes. Finally, grafting the arginine
array present in 5.3 into a well-folded zinc finger domain (Krizek
et al., 1991) successfully endowed this domain with the traf-
ficking properties of 5.3. These experiments demonstrate that
discrete arginine arrangements embedded within a well-folded
protein can direct cytosolic access by facilitating both efficient
uptake and early endosomal escape.
RESULTS
Miniature Protein Design
To examine the effect of charge density and orientation on
cell uptake, we prepared eight miniature proteins containing
between one and six arginine residues at various positions on
the solvent-exposed a-helical surface of the hairpin fold. These
molecules also contained two arginines near the C terminus
(Figure 1A). Seven of these cationic miniature proteins were820 Chemistry & Biology 19, 819–830, July 27, 2012 ª2012 Elsevier Lcharacterized by circular dichroism (CD) spectra at 37C that
were virtually indistinguishable from that of the parent molecule
lacking additional arginines, aPP (Figure S1A available online).
The CD spectra of six were temperature-dependent with coop-
erative transitions between 49C and 67C (Figures S1B and
S1C), suggesting that they each retained a stable and character-
istic hairpin fold (Hodges and Schepartz, 2007).Miniature protein
6.3, containing the greatest number of arginine substitutions
(six), showed reduced ellipticity at 222 nm and 208 nm (Fig-
ure S1A), along with a reduced Tm of 33
C (Figures S1B and
S1C); 6.3 was not studied further. For the remaining molecules,
these CD data suggest that arginine substitution does not sig-
nificantly alter miniature protein secondary structure, and that
Figure 1B is a reasonable representation of the arginine side-
chain arrangement in miniature proteins 2.1, 2.2, 3.2, 4.2, 4.3,
5.2, and 5.3.
Cell Uptake
Initially we used flow cytometry to assess the influence of
arginine number and orientation on miniature protein uptake. In
preliminary studies, we evaluated molecules labeled with fluo-
rescein on their C-termini (as denoted with superscript F). To
ensure that our experiment measured miniature proteins that
had entered cells, we included a trypsin wash just before anal-
ysis via flow cytometry. Treatment of HeLa cells with 5 mM
aPPF, 2.1F, 2.2F, or 3.2F resulted in only small increases (<3-
fold) in cell fluorescence, while treatment with 4.2F, 4.3F, 5.2F,
or 5.3F resulted in increases in cell fluorescence between
7- and 40-fold (Figure 1C). We therefore chose to focus on
miniature proteins showing significant uptake and confirmedtd All rights reserved
Figure 2. Arginine Topology Controls Cell
Binding and Uptake
(A) Evaluation of cell surface binding of rhoda-
mine-labeled cationic miniature proteins and
peptides in the absence of endocytosis and
removal by trypsin treatment. HeLa cells were
treated with 1 mM of the indicated rhodamine-
labeledmolecule for 30min. Cell were then treated
with trypsin (0.05%, 10 min, 37C) or PBS before
washing and analysis by flow cytometry. MFI,
mean fluorescent intensity.
(B) Fraction of cell-associated fluorescence
remaining after trypsin treatment. These data
represent the ratio of black to grey bars shown
in (A).
(C) Comparison of the relative uptake by HeLa
cells of the indicated rhodamine- and fluorescein-
labeled miniature proteins (black and gray bars,
respectively) after 30 min. The MFI for each
sample is shown normalized to a control sample
treated with aPP labeled with the same fluo-
rophore. The mean ± SE is shown.
(D–F) When added to HeLa cells, AlexaFluor-488-
transferrin (Tf488) (D) colocalizes with AlexaFluor-
546-labeled transferrin (Tf546) (E) and rhodamine-
labeled miniature proteins and peptides (F).
Perfect colocalization is characterized by a
Pearson’s R value (R) equal to 1, while R values
near 0 represent little or no colocalization. The correlation value observed when cells were treated with both Tf488 and Tf546 is 0.905.
(G) When added with Tf488, aPPR shows little intracellular signal. Rhodamine-labeled cationic miniature proteins and Tf546 are shown in red, Tf488 is shown in
green, and Hoescht (nucleus) is shown in blue.
Error bars shown represent mean ± SE. See also Figure S2.
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Endosomal Escape of Minimally Cationic Proteinsthese results by synthesizing analogs labeled instead with tet-
raethyl rhodamine sulfate (denoted with superscript R), a dye
with several desirable properties, including resistance to photo-
bleaching and an emission spectrum unaffected by pH changes
and far from the autofluorescence spectrum of cells (Ferna´ndez-
Sua´rez and Ting, 2008). As found for miniature proteins labeled
with fluorescein, rhodamine-labeled miniature proteins contain-
ing four or five a-helical arginines were taken up efficiently, in
some cases (5.2R and 5.3R) more efficiently than TatR or Arg8
R
(Figure 2A).
Because previous studies have shown that cell-penetrating
peptides, including Tat and Arg8, bind to cell-surface proteogly-
cans (Payne et al., 2007), we verified that trypsin treatment
removed miniature proteins that were bound to the cell surface.
Peptides and proteins that enter the cell are inaccessible to
trypsin added to the culture media (Frankel and Pabo, 1988).
Therefore, we arrested membrane traffic by incubating cells at
4C (Hanover et al., 1984; Vonderheit and Helenius, 2005) for
15 min prior to and during a 30 min treatment with 1 mM 4.2R,
4.3R, 5.2R, 5.3R, TatR, Arg8
R, or aPPR. After incubation, cells
were washed with PBS and incubated with 0.05% trypsin or
PBS (as a control) before analysis by flow cytometry. These
results were compared to those obtained when cells were incu-
bated at 37C and treated with trypsin (Figure 2A). Cationic mini-
ature proteins 4.2R, 4.3R, 5.2R, and 5.3R bound to cells between
2.7-fold and 35-fold more than aPPR and in some cases (5.2R
and 5.3R) to an extent comparable to that of TatR and Arg8
R.
For cells incubated at 4C, trypsin treatment decreased the fluo-
rescent signal between 77% and 89% (Figure 2B). These data
confirm that at 4C, incubation of cells with 1 mM cationic minia-Chemistry & Biology 19,ture protein leads to little if any cell uptake, and confirms that the
vast majority of material bound to the cell surface is degraded
and/or effectively removed by trypsin treatment. Comparison
of the uptake of rhodamine- and fluorescein-labeled miniature
proteins (Figure 2C) shows that cell uptake depends on arginine
density: miniature proteins containing four arginine residues
clustered on two helical faces were taken up more efficiently
than those containing four arginines on three helical faces
(Figures 1C, 2A, and 2C). Molecules containing five a-helical
arginines were taken up to a similar extent, irrespective of
density, revealing that among these molecules the impact of
arginine arrangement was smaller. Consistent with our previous
work (Smith et al., 2008), the cationic miniature proteins 5.2R and
5.3R are taken up with an efficiency R2-fold better than that of
Tat or Arg8, despite the fact that they possess twice the mass
and fewer (7 rather than 8) positive charges.
Cationic Miniature Proteins Traffic First into Endocytic
Vesicles
To better understand the uptake pathway, we treated HeLa cells
with rhodamine-labeled miniature proteins in the presence of
transferrin labeled with AlexaFluor-488 (Tf488) and quantified
fluorescence overlap using confocal microscopy. Transferrin is
rapidly internalized from the plasma membrane into endocytic
vesicles (Hanover et al., 1984; Lakadamyali et al., 2006), and
observing transferrin within rhodamine+ vesicles would suggest
that the vesicles were endocytic in nature, originating from the
plasma membrane. We incubated HeLa cells for 30 min with
Tf488 (25 nM) and 1 mM 4.2R, 4.3R, 5.2R, 5.3R, TatR, or Arg8
R
before washing with media, staining with Hoescht (to visualize819–830, July 27, 2012 ª2012 Elsevier Ltd All rights reserved 821
Figure 3. Translocation of GR-GFP after
Treatment with Dexamethasone and Cer-
tain Dexamethasone-Labeled Miniature
Proteins and Peptides
(A) HeLa cells transfected with GR-GFP (which
appears black in the top row) after no treatment (–)
or treatment with 1 mM dexamethasone (Dex) or
1 mM aPPDex for 30 min at 37C. The lower panel is
an overlay of the GFP signal, shown in green, and
the nuclear Hoescht signal, shown in blue.
(B) Quantification scheme.
(C) Quantification of the changes visible in (D). ns,
not significant; *p% 0.05, ***p% 0.001, ANOVA.
See also Figure S3.
(D) Visualization of the change in GR-GFP locali-
zation after treatment with 1 mM Dex-labeled
miniature protein or peptide for 30 min.
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(Figures 2D–2F). Cells treated with Tf488 showed small, discrete
areas of intense green fluorescent signal. Treatment with aPPR
led to little or no red fluorescent signal (Figure 2G), confirming
earlier results showing that aPPR is not taken up efficiently. By
contrast, HeLa cells treated with 1 mM 4.2R, 4.3R, 5.2R, 5.3R,
TatR, or Arg8
R showed red fluorescent puncta throughout the
cytosol in a distribution similar to that seen with Tf488 and at
levels that qualitatively reproduce the trends detected by flow
cytometry (Figure 2F). The fluorescent signals from Tf488 and
Tf546 were highly correlated (Figure 2E), as were, with one excep-
tion, the fluorescent signals from Tf488 and rhodamine-labeled
miniature proteins/peptides (R488,rhodamine = 0.619–0.779). Taken
together, these data suggest that transferrin and cationic minia-
ture proteins/peptides 4.2R, 5.2R, 5.3R, TatR, and Arg8
R are taken
up into the same endocytic compartments. Miniature protein
4.3R is also taken up into a transferrin+ compartment, but the
correlation (R488,rhodamine = 0.493) is lower, possibly because
the uptake is low (Figure 2F). Additional experiments to assess
whether peptide trafficking was affected by fluorophore identity
confirmed that rhodamine- and fluorescein-labeled variants of
cationic miniature proteins, as well as Tat and Arg8, traffic
together within cells, as indicated by highly correlated rhoda-
mine and fluorescein intensities (R > 0.6, p < 1 3 1010;
Figure S2).
Certain Cationic Miniature Proteins Reach
the Cytoplasm
Polypeptides and peptide mimetics showing cellular uptake
by flow cytometry may remain trapped in endosomes and fail
to reach the cytosol (Yu et al., 2011 and Maiolo et al., 2004).
Previous assays for the cytosolic localization of peptide- or pep-
toid-dexamethasone (Dex) conjugates exploited the interaction
of the Dex-labeled molecule with the ligand-binding domain of
the cytosolic glucocorticoid receptor (GR), which led eventually
to the transcription of luciferase and its detection in cell lysates822 Chemistry & Biology 19, 819–830, July 27, 2012 ª2012 Elsevier Ltd All rights reserved40–48 hr later (Yu et al., 2005). Recog-
nizing that treatment of cells with Dex
leads to rapid (15 min) nuclear accumula-
tion of a GR-green fluorescent protein
fusion (GR-GFP) (Carey et al., 1996), we
asked whether microscopy could providea rapid assay for cytosolic localization by revealing the nuclear
accumulation of GR-GFP in the presence of peptide-Dex
conjugates.
To test this hypothesis, HeLa cells transiently transfected
with GR-GFP were incubated for 30 min with between 0 and
10 mM Dex (Figure 3A and Figure S3A). When Dex was absent
from the incubation media, these cells exhibited GFP signal
throughout the cytoplasm and the nucleus (Figure 3A). Addition
of between 3 nM and 10 mM Dex led to a dose-dependent
decrease in the cytosolic GFP signal and a concomitant increase
in the nuclear GFP signal (Figure S3A). We quantified these
changes using the automated image processing package Cell-
Profiler (Carpenter et al., 2006) to measure the ratio of the
median GFP signal in the nucleus to the median signal within
a 2 mm region surrounding the region of cytosol (the ‘‘transloca-
tion ratio’’ [TR]; Figure 3B). TR values near 1 indicate equivalent
intensity between the nucleus and the surrounding region. Treat-
ment of HeLa cells with 1 mM Dex for 30 min resulted in an
increase in the TR from 1.07 ± 0.02 to 3.93 ± 0.14 (p = 1.92 3
1022, versus untreated cells, two-tailed t test), roughly 90.5%
of the value achieved with a 10-fold higher concentration (Fig-
ure 3C). We therefore chose the lower concentration for subse-
quent studies.When cells transfected with GR-GFPwere treated
for 30 min with 1 mM aPPDex, virtually no change in GR-GFP
localization or the TR was observed (1.41 ± 0.09 versus 1.25 ±
0.04, p = 0.1473; two-tailed t test; Figures 3A and 3C). These
data are consistent with the observation that aPPR fails to enter
cells and with previous results (Yu et al., 2005) showing that
simply adding the Dex label does not confer upon an otherwise
cell-impermeable peptide the ability to reach the cytoplasm.
We next evaluated the extent to which Dex-labeled miniature
proteins, as well as Tat and Arg8, induce the nuclear transloca-
tion of GR-GFP (Figures 3C and 3D). Treatment of HeLa cells ex-
pressing GR-GFP with 1 mM 5.3Dex for 30 min led to a large
increase in TR (3.1 ± 0.1) compared to both an untreated sample
(–) (p = 2.683 1048, ANOVA with Bonferroni post-test) and one
Figure 4. Endocytosis Is Required for Cytosolic Access
(A) Confocal microscopy images of HeLa cells treated with the indicated rhodamine- or AlexaFluor488-labeled peptide or miniature protein and various endo-
cytosis inhibitors.
(B–E) Translocation ratio after treatment of HeLa cells with 1 mMDex, 5.3Dex, TatDex, Arg8Dex, or aPPDex in the presence (black bars) or absence (gray bars) of
various inhibitors of endocytosis, including 80 mM dynasore (B), 5 mMmethyl-b-cyclodextrin (MbCD) (C), 50 mMEIPA (D), and 200 nM bafilomycin (E). *p% 0.05;
***p% 0.001, ANOVA with Bonferroni post-test. Error bars shown represent mean ± SE.
See also Figure S4.
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1 mM 4.2Dex, 4.3Dex, or 5.2Dex for 30 min led to a small or absent
increase in nuclear GFP signal, and to TRs (1.18 ± 0.04, 1.92 ±
0.10, and 1.77 ± 0.11, respectively) that were not significantly
different from those of cells treated with aPPDex. The TRs
measured after treatment of cells with Arg8
Dex (2.19 ± 0.13) or
TatDex (2.85 ± 0.10) showed an increase over those of control
samples treated with aPPDex (Arg8
Dex, p = 0.0053; TatDex, p =
2.543 109), and they were comparable to those of cells treated
with 5.3Dex. Control experiments verified that the affinities of
Dex-labeled cationic miniature proteins and peptides for the
human glucocorticoid receptor in vitro were similar (between 1
and 36 nM), though they were all slightly poorer than Dex itself
(0.1 nM, see Figures S3B–S3G).
We considered that degradation of miniature proteins could
lead to GR-GFP activation through release of the Dex moiety.
While aPPR, 5.2R, and 5.3R are cleaved by cathepsin D (and
to a smaller extent cathepsin L) in vitro (Figures S6D–S6F),
high-performance liquid chromatography analysis of whole-
cell lysates revealed minimal to no cleavage of the aPPR and
5.3R backbones in cells under the conditions of the translocation
assay (Figures S3H and S3I). The stability of aPPR and 5.3R under
these conditions minimizes the possibility that the increased TR
observed in the presence of 5.3Dex results from increased degra-
dation or protease susceptibility of this protein compared to
aPPDex or 5.2Dex. To further validate the results of the transloca-
tion assay, we generated cytoplasmic extracts from HeLa cells
treatedwith rhodamine-labeledminiature proteins using strepto-
lysin O (SLO) (Androlewicz et al., 1993). High-performance liquid
chromatography analysis of the SLO extracts from HeLa cellsChemistry & Biology 19,treated with aPPR showed little to no fluorescent material, while
analysis of cytoplasmic extracts from HeLa cells treated with
5.3R confirmed the presence of intact 5.3R (Figures S6D–S6E).
Analysis of cytoplasmic extracts from HeLa cells treated with
TatR or Arg8
R also showed fluorescent material, but with reten-
tion times distinct from that of the starting material (Figures
S6G and S6H), consistent with previous observations (Palm
et al., 2007) that unstructured cell-penetrating peptides can be
rapidly degraded. Cytoplasmic SLO extracts contained 4.4%
of the 5.3R present within whole cell extracts (comparing data
in Figure S3I with Figure S6E), while SLO extracts of HeLa cells
treated with aPPR showed no detectable material (lower limit
of detection = 0.5%; Figure S6D).
Cytoplasmic Access Requires Active Endocytosis
Two limiting models have been invoked to explain the trafficking
of cationic peptides and proteins across the plasma membrane
and into the cytoplasm. One model invokes ion-pair-guided
passive membrane diffusion (Rothbard et al., 2005); the other
invokes endocytosis followed by endosomal release. We sought
to distinguish between these models in two ways. First, we
asked whether inhibitors of endocytosis block the uptake of
cationic miniature proteins, their cytosolic localization, or both
(Figure 4). Second, we confirmed that cell-membrane integrity
is not disrupted by the presence of 1 mM cationic miniature
protein (Figure S4).
To determine whether active endocytosis is required for 5.3Dex
to reach the cytoplasm, we treated HeLa cells expressing GR-
GFP with inhibitors of endocytosis before and during exposure
to 1 mM 5.3Dex. Clathrin-mediated endocytosis (CME),819–830, July 27, 2012 ª2012 Elsevier Ltd All rights reserved 823
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Endosomal Escape of Minimally Cationic Proteinspinocytosis, and caveolin-mediated endocytosis are dependent
on dynamin (Doherty and McMahon, 2009), whose activity is in-
hibited by the small molecule dynasore (Macia et al., 2006).
Depleting cellular cholesterol by treatment with methyl-b-cyclo-
dextrin (MbCD) also inhibits these three processes (Rodal et al.,
1999). Actin remodeling, a process inhibited by addition of N-
ethyl-isopropyl amiloride (EIPA) (Koivusalo et al., 2010) facilitates
clathrin-coated pit formation (Doherty and McMahon, 2009) and
is required for some dynamin- and cholesterol-independent en-
docytic pathways. Notably, addition of EIPA does not block the
uptake of someCME ligands such as transferrin (Koivusalo et al.,
2010).
To test the involvement of these pathways in the uptake of
cationic miniature proteins and peptides, we pretreated HeLa
cells for 30 min with 80 mM dynasore, 5 mM MbCD, or 50 mM
EIPA before adding 1 mM aPPR, 5.3R, TatR, or Arg8
R for 30 min
at 37C in the presence of inhibitor. The cells were subsequently
washed and visualized by confocal microscopy (Figure 4A). The
presence of dynasore completely blocked the uptake of 5.3R,
as well as TatR and Arg8
R, suggesting that all three molecules
are taken up in a dynamin-dependent fashion. The presence of
EIPA also dramatically reduced the uptake of all threemolecules,
suggesting a role for actin metabolism in the internalization pro-
cess. MbCD completely blocked the uptake of 5.3R and TatR, but
not Arg8
R. Surprisingly, cellular uptake of Arg8
R was increased in
the presence of MbCD, leading to diffuse fluorescence through-
out the cytosol, a pattern not observed in the absence of the
inhibitor.
We next measured the effect of blocking endocytosis on the
ability of 5.3Dex, TatDex, and Arg8
Dex to reach the cytoplasm.
We were mindful that exchanging the rhodamine label for Dex
could alter the physical properties of the molecule, as well as
the manner in which it trafficked in cells. HeLa cells transfected
with GR-GFP were pretreated for 30 min with the same inhibitors
prior to the addition of 1 mM of either Dex (positive control),
aPPDex (negative control), 5.3Dex, TatDex, or Arg8
Dex for 30 min
at 37C (Figures 4B–4D). The cells were then washed and
imaged to measure the TR. None of the endocytosis inhibitors
altered the TR calculated for cells treated with aPPDex. However,
all three inhibitors reduced to background levels the TR calcu-
lated after treatment with 5.3Dex or TatDex, and both dynasore
and EIPA reduced the TR observed after treatment with Arg8
Dex.
As anticipated from the microscopy results discussed above,
the cytoplasmic access of Arg8
Dex was not decreased in the
presence of MbCD. Neither EIPA nor dynasore blocked the
increase in the TR calculated after treatment with Dex, but
MbCD reduced this increase by 53%, presumably the result of
direct complexation of free Dex by MbCD (Moya-Ortega et al.,
2010). The results with Arg8
R notwithstanding, these data
support the contribution of endocytic pathways to the uptake
of cationic miniature proteins and peptides, and not a model
based on passive diffusion.
An endosome’s acidification begins almost immediately upon
its scission from the plasma membrane, as its lumen no longer
communicates with the surrounding media. Bafilomycin is a
potent inhibitor of the vesicular ATPase (Yoshimori et al.,
1991), and its addition to culture media prevents endosomal
acidification (Yoshimori et al., 1991; Fischer et al., 2004). To
determine whether low vesicular pH was required for endosomal824 Chemistry & Biology 19, 819–830, July 27, 2012 ª2012 Elsevier Lescape, we pretreated HeLa cells expressing GR-GFP with
200 nM bafilomycin for 1 hr before exposing them to 1 mM
Dex, 5.3Dex, TatDex, Arg8
Dex, or aPPDex (Figure 4E). Treatment
with bafilomycin did not alter the effect of Dex or aPPDex on
the TR, but it completely blocked the increase in TR seen after
cells were exposed to 5.3Dex (p = 1.4 3 1011), TatDex (p =
5.3 3 1011), or Arg8
Dex (p = 8.2 3 106). Thus, while 5.3Dex,
TatDex, and Arg8
Dex reach the cytoplasm, they fail to do so in
the absence of endosome acidification. This finding further
supports the model that these molecules do not penetrate the
plasma membrane directly, but rather escape to the cytoplasm
from acidified endocytic vesicles.
Escape to the Cytoplasm from Early Endosomes
Phospholipids present in newly formed clathrin-coated vesicles
andmacropinosomes undergo rapidmodification resulting in the
recruitment of Rab5 (Lakadamyali et al., 2006; Zoncu et al.,
2009). Rab5 is a master regulator of endosome biogenesis (Zei-
gerer et al., 2012) and recruits additional cellular factors required
for vesicle maintenance, fusion, and maturation, including the
phosphatidyl inositol (PI) 3-OH kinase (PI3K) Vps34 (Christofori-
dis et al., 1999b). The resulting early endocytic compartment
mixes via homotypic fusion with other Rab5+ vesicles (Stenmark
et al., 1994) and delivers cargo to other cellular locales through
the budding off of transport vesicles (Puthenveedu et al., 2010)
or Rab conversion (Rink et al., 2005). While some cargo (such
as transferrin) is recycled to the cell surface, other cargo, such
as low-density lipoprotein, epidermal growth factor (Cantalupo
et al., 2001), and several types of virus (Vonderheit and Helenius,
2005) are delivered to late endosomes, marked by Rab7, for
degradation in lysosomes (Huotari and Helenius, 2011). To char-
acterize the intracellular route taken by 5.3R, TatR, and Arg8
R, we
looked for overlap of these molecules with markers of endocytic
uptake and GFP-tagged Rab proteins. We also used small
molecule inhibitors and dominant-negative Rab variants to test
the cellular activities required for 5.3Dex, TatDex, and Arg8
Dex to
enter the cytoplasm.
Guided by the observation that 5.3R colocalizes with trans-
ferrin (Figure 3), a substrate known to internalize into Rab5+
vesicles (Lakadamyali et al., 2006), we asked whether 5.3R
was also present in Rab5+ vesicles. HeLa cells were trans-
fected with GFP-Rab5 and treated for 30 min with 1 mM 5.3R.
When these cells were examined by confocal microscopy,
66% of the rhodamine signal overlapped with the signal from
GFP-Rab5, confirming that 5.3R is present in Rab5+ vesicles
(Figure 5A). Because Rab5 vesicles rapidly deliver their cargo
to downstream vesicles (Rink et al., 2005), we also evaluated
colocalization of 5.3R with Rab7-GFP (Figure 5C). HeLa cells
transfected with Rab7-GFP and treated with 5.3R as above
showed a large fraction (87%) of the rhodamine signal located
in the Rab7-GFP compartment, confirming that 5.3R enters
both early (Rab5+) and late (Rab7+) endosomes. We found no
overlap between 5.3R, TatR, or Arg8
R and galT-GFP (Cole
et al., 1996), a marker of the golgi (Figure S5). To test whether
trafficking of 5.3R could be arrested at the Rab5 stage, we over-
expressed a GTPase-inactive Rab5 mutant, Rab5Q79L (Sten-
mark et al., 1994), that blocks delivery of cargo to late endo-
somes and arrests vesicle maturation (Rink et al., 2005).
Observation of HeLa cells transfected with Rab5Q79L-GFP andtd All rights reserved
Figure 5. Differential Trafficking and Re-
lease of Miniature Protein 5.3, Tat, and Arg8
(A–I) HeLa cells transfected with the indicated GFP
fusion protein were treated with 1 mM 5.3R (A–C),
Arg8R (D–F), or TatR (G–I) before being washed
and imaged by confocal microscopy. Colocaliza-
tion of 5.3R, TatR, and Arg8
R with Rab5-GFP is
moderate ([A], [D], and [G]) but can be increased
by arresting Rab5 maturation via overexpression
of Rab5Q79L-GFP ([B], [E], and [H]. 5.3R, TatR, and
Arg8
R are delivered to Rab7+ endosomes ([C], [F],
and [I]. Fraction of red fluorescence overlapping
green is shown for each image (R ˛ G). Scale bars
are 10 mm.
(J) Transfection with Rab5Q79L-GFP does not
block increase of the translocation ratio seen after
treatment with dexamethasone, 5.3Dex, or Arg8
Dex,
but decreases the translocation ratio measured
after treatment with TatDex (p = 0.005).
(K) HeLa cells were treated with 200 nM wort-
mannin for 30min before treatment with 1 mMDex,
5.3Dex, TatDex, Arg8
Dex, or aPPDex for 30 additional
min in the continued presence of the drug. Wort-
mannin decreased the translocation ratio mea-
sured after treatment with TatDex (p = 8.1 3 1015)
and Arg8
Dex (p = 2.3 3 105). Error bars shown
represent mean ± SE. ns, not significant; *p %
0.05; **p % 0.01; ***p % 0.001, ANOVA with
Bonferroni post-test.
See also Figure S5.
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protein localized to enlarged GFP+ endosomes (Figure 5B),
suggesting that arresting early endosome maturation arrests
trafficking of 5.3R at the Rab5+ stage. Similar results were
seen with Arg8
R and TatR (Figures 5D–5I). These data suggest
that 5.3R, TatR, and Arg8
R follow a shared path through
Rab5+ and then Rab7+ vesicles and provide a starting point
to ask which, if any, of these trafficking events are required to
reach the cytoplasm.
To identify the point or points along the endocytic pathway at
which these three molecules escape to the cytsosol, we blocked
vesicle maturation through overexpression of Rab5Q79L-GFP
and assayed for cytosolic localization using dual-color micros-
copy and an orthogonally labeled GR-mCherry (Figure 5J). The
TR of untreated HeLa cells expressing Rab5Q79L-GFP or
Rab5-GFP and GR-mCherry was near unity (TR = 1.32 ± 0.07),
as expected, and remained unchanged after treatment for
30 min with 1 mM aPPDex (TR = 1.25 ± 0.04). As expected, the
TR values of Rab5Q79L-GFP- and Rab5-GFP-expressing cells
increased after treatment for 30 min with 1 mM of Dex (TR =
2.45 ± 0.21 and 2.24 ± 0.15 for Rab5-GFP- and Rab5Q79L-
GFP-expressing cells, respectively). Treatment with 1 mM
5.3Dex resulted in TR values that were similar regardless of
whether cells were transfected with wild-type Rab5-GFP orChemistry & Biology 19, 819–830, July 27, 2012Rab5Q79L-GFP (1.80 ± 0.08 versus
1.90 ± 0.07, respectively); similar findings
were observed when cells were treated
with Arg8
Dex (1.59 ± 0.11 versus 1.60 ±
0.09, respectively). By contrast, treat-ment with TatDex resulted in TR values that differed depending
on whether cells were transfected with wild-type Rab5-GFP or
Rab5Q79L-GFP (1.57 ± 0.04 versus 1.26 ± 0.03, respectively;
p = 0.0057). Thus, arresting vesicle maturation with the
GTPase-inactive Rab5 mutant Rab5Q79L blocked the ability of
TatDex to reach the cytoplasm but had no effect on 5.3Dex or
Arg8
Dex. These findings suggest that 5.3 and Arg8 escape to
the cytoplasm from Rab5+ vesicles, whereas Tat can only
escape later along the endocytic pathway.
To arrest endocytic traffic at an earlier stage, we treated cells
with 200 nM wortmannin, a pharmacologic inhibitor of PI3K that
blocks the maturation of Rab5+ vesicles (Christoforidis et al.,
1999a) by decreasing the recruitment of Rab5 effectors that
bind simultaneously to Rab5 and PI-3-phosphate-containing
membranes (Zoncu et al., 2009). Wortmannin treatment blocked
the increase in TR seen after treatment with TatDex and Arg8
Dex
by 72% and 77%, respectively (Figure 5K). In contrast, the TR
increase seen after treatment with 5.3Dex in the presence or
absence of wortmannin was similar (2.36 ± 0.08 versus 2.76 ±
0.10), confirming that 5.3Dex escapes at or before the earliest
Rab5+ state. Taken together, these data suggest that arresting
vesicle maturation inhibits the cytosolic access of both TatDex
and Arg8
Dex, but that 5.3Dex is capable of leaving these earliest
vesicles and reaching the cytoplasm.ª2012 Elsevier Ltd All rights reserved 825
Figure 6. The 5.3 Arginine Motif Is Trans-
portable
(A) Primary sequences of a zinc finger domain (ZF)
and an analogous domain inwhich all five arginines
have been substituted with alanine (ZF5.3).
(B) Translocation of GR-GFP after treatment with
1 mM SDex or the indicated Dex-labeled molecule
in the presence and absence of endocytic inhibi-
tors, as described in Figure 5.
(C) Colocalization of Rab5-GFP (green) with
ZF5.3R (red) and Hoescht 33342 (blue).
(D) Rab5Q79L-GFP overexpression does not
block increase of the translocation ratio seen after
treatment with ZF5.3Dex. Error bars shown repre-
sent mean ± standard error. ns, not significant;
***p < 0.001, ANOVA with Bonferroni post-test.
See also Figure S6.
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Modified with 5.3 Arg Motif
The results described above suggest that the arginine motif
present in the aPP variant 5.3 facilitates the release of this
molecule from Rab5+ endosomes into the cytosol. Notably,
the regioisomer 5.2, although also decorated with five arginine
side chains on the external a-helix face, is released much less
efficiently (Figure 3). To determine whether the arginine motif
present on the 5.3 a-helix is transportable, that is, whether it
can promote the cytosolic localization of other a-helix-contain-
ing proteins, we turned to the zinc finger proteins, as their thera-
peutic potential is well known (Sera, 2009; Urnov et al., 2010).We
began with the sequence of CP1, a single zinc finger possessing
high zinc ion affinity (Krizek et al., 1991), and prepared a dexa-
methasone-labeled variant (ZF5.3Dex) whose a-helix was
substituted with the arginine motif in 5.3 (Figure 6A), a change
that neither prevented zinc binding nor significantly changed
the secondary structure as measured by CD (Figure S6A). We
next evaluated the extent to which ZF5.3Dex induced the nuclear
translocation of GR-GFP when compared with a variant lacking
the argininemotif (ZFDex) (Figure 6B). Treatment of HeLa cells ex-
pressing GR-GFP with 1 mM ZF5.3Dex for 30 min led to a large
increase in TR (2.4 ± 0.09) compared to both an untreated
sample (0.9 ± 0.05) and one treated with ZFDex (1.4 ± 0.05) (p <
0.0001, ANOVA with Bonferroni post-test). Control experiments
confirmed that ZF5.3R can be recovered from cytosolic extracts
of HeLa cells treated with ZF5.3R (Figure S3L), and that the
peptide backbone of ZF5.3 is not significantly degraded under
the conditions in this assay (Figure S6I). As observed with 5.3,
inhibition of early endocytic events with dynasore, bafilomycin,
EIPA, or methyl-b-cyclodextrin reduced to background levels
the increase in translocation ratios observed in the presence of
ZF5.3Dex (Figure 6B). Furthermore, as observed with 5.3, when
cells expressing GFP-Rab5 were treated with ZF5.3R and exam-
ined by confocal microscopy, 68% of the rhodamine channel826 Chemistry & Biology 19, 819–830, July 27, 2012 ª2012 Elsevier Ltd All rights reservedoverlapped with the signal from GFP-
Rab5, confirming that ZF5.3R is present
in Rab5+ vesicles (Figure 6C). Finally, as
observed with 5.3, the TR of cells treated
with ZF5.3R was unaffected when endo-
cytic traffic was arrested by treatmentwith wortmannin or overexpression of dominant-negative
Rab5Q79L-GFP (Figures 6B and 6D). Together, these data imply
that the argininemotif in ZF5.3, like the argininemotif in 5.3, func-
tions to promote endocytic uptake and release from early Rab5+
endosomes, and emphasizes the potential of helical-arginine
display for modulating the escape of cationic miniature proteins
and peptidomimetics from early endosomes into the cytoplasm.
Although further work is necessary to evaluate how broadly the
motif identified here canbe applied, these results provide a struc-
tural andmechanistic framework for efficiently increasing the cell
permeabilities of therapeutic peptides and proteins.We estimate
that between 1% and 5% of the intracellular pool of 5.3 and
ZF5.3 enters the cytosol.
DISCUSSION
The interfaces that form between and among proteins and
DNA—often large, flat, and polar—do not often resemble those
that bind small-molecule substrates or traditional inhibitors (Rut-
ledge et al., 2003). Targeting these ‘‘undruggable’’ interfaces is
a task well suited to protein and peptide ligands but can only
be successful if such molecules reach their cytosolic targets.
Unfortunately, the very properties that endow peptide mimetics
with their promise—size and polarity—are precisely those prop-
erties forbidden by Lipinski’s rules (Lipinski et al., 2001). The
challenge, therefore, is to identify the determinants that guide
the uptake of peptide-like molecules and the mechanisms
through which they gain cytosolic access, generating a new
set of rules applicable to large peptidic molecules and their
mimetics. Advancing this goal has been constrained by the
absence of a rapid and robust assay capable of distinguishing
between peptide-like molecules that remain trapped within en-
dosomes and those that escape into the cytosol.
Here we took advantage of developments in automated image
analysis and the rapid cytoplasmic-to-nuclear translocation of
Figure 7. Scheme Illustrating the Stepwise
Pathway of Traffic Taken by 5.3, ZF5.3, Tat,
and Arg8 from the Cell Exterior into the
Cytosol
The path taken by 5.3, ZF5.3, Tat and Arg8 from
the cell exterior to the cytosol begins with and
requires endocytosis from the plasma membrane.
5.3, ZF5.3, Tat, and Arg8 bind to the cell surface
and traffic into early endosomes, which rapidly
acquire Rab5, followed by Vps34, a lipid kinase
responsible for generating PI3P. Inhibition of
Vps34 by Wortmannin fails to block escape of 5.3
or ZF5.3 (see Figures 5 and 6), indicating these
molecules can escape vesicles prior to this stage.
Rab5 and PI3P recruit Rab5 effectors, beginning
endosome maturation. Recruitment of Rab7 leads to the formation of late endosomes (LE). The Rab5+-to-Rab7+ transition, which is blocked following trans-
fection with Rab5Q79L, is not required for 5.3 or ZF5.3 to access the cytoplasm, but decreases the escape of Tat (see Figure 5), suggesting Tat escapes later in
the endocytic pathway. Arg8 escape is blocked by wortmannin treatment but not by transfection with Rab5Q79L, suggesting escape begins late in the Rab5
stage but prior to the Rab7 stage. Endosomes are progressively acidified, a process blocked by bafilomycin (structure shown) and required for 5.3, ZF5.3, Tat,
and Arg8 to reach the cytoplasm.
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mulation of a GR-GFP fusion, reports on the cytoplasmic entry
of traditionally impermeant molecules tagged with the GR
ligand Dex. This assay offers advantages in both speed and
cost over a first-generation assay developed by Kodadek and
colleagues (Yu et al., 2005), as it provides a readout in individual
living cells within 30 min (as opposed to 48 hr) and eliminates
the requirement for cell lysis or costly enzymatic substrates.
With this assay, we measured differences in the cytosolic local-
ization of four actively endocytosed miniature proteins and
identified 5.3 and ZF5.3 as minimally cationic proteins whose
rapid cytosolic localization is equivalent to or better than Tat
and Arg8. Furthermore, 68 of 71 cells (96%) treated with
5.3Dex showed significant changes in GR-GFP localization,
whereas only 2 of 55 cells treated with Dex-aPP (3.6%) showed
increased translocation ratios, highlighting that minimally
cationic protein domains containing the 5.3 motif enter the cyto-
plasm of most cells. The large differences in cytosolic localiza-
tion among the set of closely related miniature proteins empha-
size that distinct structural determinants control both endocytic
uptake and endosomal release. Both 5.2 and 5.3 possess mass
to charge ratios of 0.73 charge units per kDa, near the value
suggested by Cronican et al. (2011) to predict cell penetrating
activity, but less than +36 GFP (+1.27/kDa). Nevertheless,
even among proteins with similar mass to charge ratios, uptake
appears to be favored by clustered a-helical arginine side
chains, whereas release requires a more dispersed arginine
array.
Coupling this new assay for cytosolic localization with live-cell
confocal microscopy allowed us to further clarify contrasting
models for the intracellular pathway taken by cationic miniature
proteins and peptides en route to the cytoplasm. At low concen-
trations, none of the molecules studied here crossed the plasma
membrane directly. Miniature protein 5.3 and the zinc finger
module ZF5.3 enter into and escape from early (Rab5+) endo-
somes. In contrast, Tat and Arg8, which are also present in
Rab5+ vesicles, require delivery to downstream Rab7+ vesicles
or the recruitment of Rab5 effectors in order to reach the cyto-
plasm (Figure 7). The differences in arginine/lysine number and
orientation in 5.3, ZF5.3, Tat, and Arg8 will likely affect theirChemistry & Biology 19,side chain pKa values and thus the overall charge of each mole-
cule at any given pH. Thus, it is possible that the distinct arginine
array in 5.3 and ZF5.3 favors formation of a critical protonated
species within the early endosome (pH6.5), whereas the lower
pH present in lysosomes may be required to generate an equiv-
alent state for Tat and Arg8. Alternatively, the distinct arginine
array in 5.3 and ZF5.3 could represent an export signal for
cellular machinery that has yet to be identified.
SIGNIFICANCE
Proteins and other peptidic molecules able to cross biolog-
ical membranes possess promise both as therapeutics and
as agents for delivery of macromolecules, such as siRNA,
to the cytoplasm of target cells. In a broader sense, proteins
and peptides that effectively traffic across membranes offer
the potential to illuminate fundamental principles of cell
biology. In this work we identified two small folded proteins,
the cationic miniature protein 5.3 and the zinc finger module
ZF5.3, that achieve cytosolic access through rapid internal-
ization and efficient escape from Rab5+ endosomes. The
trafficking pathway that we mapped for these molecules is
similar to that taken by botulinum and anthrax toxins, which
also escape from early endosomes (Simpson, 2004). The
pathways followed by Tat and Arg8, however, resemble
those of SV40 (Vonderheit and Helenius, 2005) and HIV-1 (Vi-
dricaire and Tremblay, 2005) and require transport beyond
early Rab5+ endosomes to gain cytosolic access. This
difference in trafficking indicates that the ability of 5.3 and
ZF5.3 to rapidly escape from early endosomes is a unique
feature not shared by canonical cell-penetrating peptides,
and it implies the existence of distinct signals, encodable
within short peptide sequences, that favor early versus late
endosomal release. Identifying these signals and under-
standing their mechanistic basis will illustrate how cells
control the movement of endocytic cargo and may allow
researchers to engineer molecules to follow a desired
delivery pathway for rapid cytosolic access. Collectively,
our investigations represent a starting point for the optimi-
zation of well-folded functional cell-penetrating proteins819–830, July 27, 2012 ª2012 Elsevier Ltd All rights reserved 827
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cytoplasmic protein function.
EXPERIMENTAL PROCEDURES
Cell Culture and Transfections
HeLa cells (ATCC,Manassas, VA) were grown in T-75 culture flasks containing
Dulbecco’s modified essential medium (DMEM; GIBCO Cat. #11995-065,
Invitrogen, Carlsbad, CA) supplemented with 10% fetal bovine serum, and
100 U/ml each penicillin and streptomycin. Transient transfections were per-
formed using Fugene 6 or XtremeGene HP (Roche, Indianapolis, IN) and proto-
cols recommended by the manufacturer. Plasmids encoding Rab5-GFP and
Rab5Q79L-GFP were gifts from Pietro DeCamilli. A plasmid containing Rab7-
GFP was a gift of Qing Zhong (plasmid #28047, Addgene, Cambridge, MA).
A plasmid containing GalT-EGFP was a gift of Jeniffer Lippincott-Schwartz
(Addgene plasmid #11937). A plasmid containing the glucocortcoid receptor
fused to EGFP (pK7-GR-GFP) was a gift of Ian Macara (Addgene plasmid
#15534).
Analysis of Surface Binding and Cell Uptake
HeLa cells grown to 90% confluency were dissociated from flasks by incu-
bation for 15 min at 37C with 2 ml PBS, 1 mM EDTA, and 1 mM EGTA. Cells
were collected in warmed media, and aliquots (150 ml, 200,000 cells) distrib-
uted to 96 well plates. The cells were incubated at 4C or 37C for 10 min,
1 mM fluorescently labeled peptide was added, and incubation continued for
an additional 30 min. Cells were then washed twice with DMEM + 10% fetal
bovine serum and treated with trypsin (30 ml per well, 0.05%, 37C 3
10min) before resuspending in 300 ml PBS. Cells were analyzed by flow cytom-
etry using an Accuri C6 flow cytometer. To confirm that trypsin treatment
removed fluorescently labeled peptide remaining on the cell surface, HeLa
cells were treated with 1 mMminiature protein or peptide at 4C to inhibit endo-
cytosis. After washing twice, the cells were then treated with trypsin (30 ml,
0.05%, 37C 3 10 min) or PBS as a control. Cells were then resuspended in
300 ml PBS before analysis by flow cytometry. Data presented are the
mean ± SEM for four biological replicates measuring the mean fluorescence
intensity of 30,000 cells. Dead cells defined by forward and side scatter
were excluded.
Colocalization of Miniature Proteins with Alexa-488-Transferrin and
Rab-GFP Fusions
To examine the colocalization of rhodamine-labeled miniature proteins or
peptides with Alexa-488-transferrin (Tf488), HeLa cells were plated (200 ml,
104 cells/well, 96 well glass bottom plates, Matrical, Spokane, WA) the day
prior to experiments. The media was replaced with 150 ml HEPES-Krebs-
Ringer’s (HKR) buffer (140 mM NaCl, 2 mM KCl, 1 mM CaCl2, 1 mM MgCl2,
10 mM HEPES [pH 7.4]) containing 1 mM hodamine-labeled molecule or
25 nM Alexa-488-transferrin (Molecular Probes, Eugene, OR) and the cells
were incubated at 37C for 30 min. The cells were then rinsed twice with
200 ml HKR buffer and nuclei were labeled by overlaying 200 ml HKR containing
300 nM Hoechst 33342 (Molecular Probes Cat. #H3570) for 5 min. Images of
cells were acquired using a PerkinElmer (Waltham, MA) LiveView spinning
disk confocal microscope fitted with a 60 3 1.2 NA objective. Colocalization
with Rab-GFP fusions was examined in an analogous way using HeLa cells
transfected with the appropriate expression plasmid. See Supplemental
Experimental Procedures online for details.
Effects of Inhibitors on Cell Uptake
HeLa cells grown for 24 hr in glass-bottom plates were incubated with HKR
buffer or HKR buffer containing 80 mMdynasore, 50 mMN-ethyl-isopropyl-ami-
loride, or 5mMmethyl-b-cyclodextrin for 30min at 37Cprior to the addition of
1 mM rhodamine-labeled miniature protein or peptide (Tat and Arg8). The cells
were washed twice with DMEM, the nuclei labeled with Hoescht, and images
acquired as described above for colocalization experiments.
GR-GFP Translocation Assay
HeLa cells transfected with pK7-GR-GFP were plated in Matrical plates as
described above. To label nuclei, the media were replaced with HKR buffer828 Chemistry & Biology 19, 819–830, July 27, 2012 ª2012 Elsevier Lcontaining 300 nM Hoescht 33342 and the cells were incubated for 30 min
at 37C. Cells were then treated with 150 ml HKR buffer or HKR buffer contain-
ing 1 mMdexamethasone, dexamethasone-labeled miniature protein, or dexa-
methasone-labeled peptides for 30 min at 37C before epifluorescence
imaging. The translocation ratio (the ratio of the median intensities of GFP in
the nuclear and surrounding region) for each cell imaged was measured using
CellProfiler (Carpenter et al., 2006). For further details see Supplemental
Experimental Procedures online.
To examine the effects of various inhibitors, HeLa cells transfected and
plated as above were pretreated with HKR buffer containing 300 nM Hoescht
and 80 mM dynasore, 50 mMN-ethyl-isopropyl-amiloride, 200 nM wortmannin,
200 nM bafilomycin, or 5 mM methyl-b-cyclodextrin for 30 min at 37C, after
which 1 mM dexamethasone, dexamethasone-labeled miniature protein, or
dexamethasone-labeled peptide was added for an additional 30 min at
37C. Cells were then analyzed as described above.
To evaluate the requirement of Rab5 activity for the ability of peptides to
reach the cytoplasm, HeLa cells were transfected with pGR-mCherry and
either Rab5-EGFP or Rab5Q79L-EGFP for 24 hr before treatment with dexa-
methasone or dexamethasone-labeled miniature proteins or peptides and
imaging as described above. Cotransfected cells expressing Rab-GFP fusions
and pGR-mCherry were identified via their characteristic pattern of green and
red fluorescence. The translocation ratio was determined using median values
of mCherry fluorescence within the nucleus and surrounding region using
CellProfiler.
Statistical Analysis
Comparisons within groups were made using ANOVA. Pairwise comparisons
within groupsweremade using Bonferroni’s post-test after finding a significant
difference using ANOVA. P values are corrected using Bonferroni’s method
(Shaffer, 1995) so that the family-wise error rate is 0.05. Otherwise, compari-
sons were made using a two-tailed t test.
Supplemental Experimental Procedures
Supplemental Experimental Procedures containing additional descriptions of
materials, polypeptide synthesis and characterization, pGR-mCherry vector
construction, circular dichroism analysis, and image acquisition and analysis
may be found online.SUPPLEMENTAL INFORMATION
Supplemental Information contains six figures, one table, and Supplemental
Experimental Procedures and can be found with this article online at http://
dx.doi.org/10.1016/j.chembiol.2012.05.022.
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Note Added in Proof
It was recently reported by Barbas and coworkers that certain combinations of
zinc finger modules can traffic to the nuclei of mammalian cells (Gaj, T. Guo, J.,
Kato, Y., Sirk, S.J., Barbas, C.F. III. Nature Meth. 10.1038/nmeth.2030).td All rights reserved
